SHOULDER INNOVATIONS, INC. (SI) Q3 2025 10-Q Quarterly Report
Filed: Nov 12, 2025Period ending Sep 30, 2025
Health Care
Surgical & Medical Instruments & ApparatusSEC EDGAR SHOULDER INNOVATIONS, INC. (SI) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 12, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
SHOULDER INNOVATIONS, INC. Q3 2025 10-Q Analysis
Risk Factors
- • New debt amendment risk: Second amendment to Trinity Loan Agreement in July 2025 raises covenant breach default risk on $15M principal
- • Updated financial risk: Net loss $32.6M for nine months ended Sept 30, 2025 vs $11.8M prior year, reflecting higher operating expenses and investment
- • Regulatory/legal risk: Trinity Loan covenants restrict mergers, acquisitions, and asset dispositions, limiting strategic flexibility and risking default consequences
- • Operational/market risk: Growth management challenges include supplier quality, inventory, skilled hiring, and distributor relationships could delay product availability
- • Financial liquidity risk: Interest payments under Trinity Loan divert cash resources; failure to comply with covenants could trigger immediate debt repayment and collateral foreclosure
SHOULDER INNOVATIONS, INC. Q3 2025 Quarterly FinancialsXBRL
Revenue
$12M
▼ -44.4% QoQ
Net Income
-$9M
▲ +63.4% QoQ
Gross Margin
76.2%
▼ -31bp QoQ
Operating Margin
-65.0%
▼ -1697bp QoQ
Net Margin
-74.3%
▲ +3858bp QoQ
ROE
-5.9%
Total Assets
$178M
EPS (Diluted)
$225.13
▲ +197.0% QoQ
Operating Cash Flow
-$9M
▲ +24.1% QoQ
Source: XBRL data from SHOULDER INNOVATIONS, INC. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on SHOULDER INNOVATIONS, INC.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.